期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

氯法拉滨在儿童白血病治疗中的应用 被引量：1

The Application of Clofarabine for Leukemia Treatment in Children
下载PDF
导出
摘要 目前儿童急性淋巴细胞白血病（acute lymphoblastic leukemia,ALL）5年无事件生存率（event-free survival,EFS）达70%以上,急性髓系白血病（acute myeloid leukemia,AML）5年EFS只有40%～50%,对于大约20%的难治性或复发性白血病患者,无论采用大剂量化疗还是造血干细胞移植,疗效都不理想,所以开发新型化疗药物是解决这一难题的重要途径之一。
作者 孟岩 于洁
机构地区 重庆医科大学附属儿童医院
出处 《儿科药学杂志》 CAS 2011年第4期52-55,共4页 Journal of Pediatric Pharmacy
关键词 儿童白血病 氯法拉滨 儿童急性淋巴细胞白血病 急性髓系白血病 造血干细胞移植 应用 治疗 无事件生存率
分类号 R733.7 [医药卫生—肿瘤]
  • 相关文献

参考文献22

  • 1Pui CH, Jeha S, Kirkpatrick P. Clofarabine [ J]. Nat Rev Drug Discov, 2005, 4 (5) : 369-370. 被引量：1
  • 2Tallman MS. New agents for the treatment of acute myeloid leukemia [ J ]. Best Pract Res Clin Haematol, 2006, 19 (2) : 311- 320. 被引量：1
  • 3Lindemalm S, Liliemark J, Juliusson G, et al. Cytotoxieity and pharmacokineties of eladribine metabolite, 2-ehloroadenine in patients with leukemia [J]. Cancer Lett, 2004, 210 ( 2 ) : 171- 177. 被引量：1
  • 4Zhenchuk A, Lotfi K, Juliusson G, et al. Mechanisms of anticancer action and pharmacology of clofarabine [ J ]. Biochem Pharmacol, 2009, 78(11 ): 1351-1359. 被引量：1
  • 5Bonate PL, Arthaud L, Cantrell WR Jr, et al. DiscovexT and development of clofarabine: a nueleoside analogue for treating cancer [J]. Nat Rev Drug Discov, 2006, 5(10): 855-863. 被引量：1
  • 6Reichelova V, Liliemark J, Albertioni F, et al. Liquid chromatographic study of acid stability of 2-chloro-2'-arabino- fluoro- 2'-deoxyadenosine, 2-chloro-2'-deoxyadenosine and related analogues [ J].J Pharm Biomed Anal, 1995, 13 (4-5) : 711-714. 被引量：1
  • 7Xie C, Plunkett W. Metabolism and actions of 2-ehloro-9-(2-deoxy-2- fluoro-beta-D-arabinofuranosyl)-adenine in human lymphoblastoid cells[J]. Cancer Res, 1995, 55(13): 2847-2852. 被引量：1
  • 8King KM, Damaraju VL, Vickers MF, et al. A comparison of the transportability, and its role in cytotoxicity, of clofarabine, cladribine, and fludarabine by recombinant human nucleoside transporters produced in three model expression systems [Jl. Mol Pharmacol, 2006, 69 ( 1 ) : 346-353. 被引量：1
  • 9Chen LS, Plunkett W, Gandhi V. Polyadenylation inhibition by the triphosphates of deoxyadenosine analogues [ J ]. Leuk Res, 2008, 32(10) : 1573-1581. 被引量：1
  • 10Curran MP, Perry CM. Clofarabine: in pediatric patients with acute lymphoblastic leukemia [ J]. Paediatr Drugs, 2005, 7 (4) : 259-264. 被引量：1

二级参考文献23

  • 1Faded S, Gandhi V, O' Brien S, et al. Results of a phase 1-2 study of clofarabine in combination with evtarabine (ara-C) in relapsed and refraetory acute leukemias. Blood, 2005,105: 940- 947. 被引量：1
  • 2Becker PS, Estey E, Petersdorf S, et al. Phase Ⅰ trial of clofarabine and high dose cytarabine with G-CSF priming (G-CLAC) for relapsed or refractory acute myeloid leukemia. Blood, 2005, 112 : absract 2964. 被引量：1
  • 3Thomas X, Lobe I, Raffoux E, et al. Intensive consolidation with clofarahine and Intermediate-dose cytarabine (CLARA) in patients with high-risk AML in first CR: the ALFA-0702 pilot study. Blood, 2008,112 :absraet 1934. 被引量：1
  • 4Faderl SB, Borthakur G, Ravandi F, et al. Results of a randomized phase 2 study of clofarabine plus cytarabine (CA) vs Clotarabine plus ldarubicin (CI) vs Clofarabine, Idarubicin, plus Cytarabine (CIA) as salvage therapy in acute myeloid leukemia (AML). Blood, 2008,112 :abstract 964. 被引量：1
  • 5Burnett A, Kell W, Hills R, et al. The feasibility of combining daunorubicin, clofarabine and gemtuzumab ozogamicin is feasible and effective. A pilot study. Blood, 2006, 108: abstract 1950. 被引量：1
  • 6Karp JE, Ricklis RM, Balakrishnan K, et al. A phase 1 clinicallaboratory study of clofarabine followed by cyclophosphamide for adults with refractory acute leukemias. Blood, 2007,110: 1762- 1769. 被引量：1
  • 7Hijiya N, Gaynon PS, Fernandez M, et al. Durable remissions observed in a phase Ⅰ/Ⅱ study of Clofarabine in combination with Etoposide and Cyclophosphamide in pediatric patients with refractory or relapsed acute leukemia. Blood, 2008,112 :abstract 2925. 被引量：1
  • 8Moufarij MA, Sampalh D, Keating M J, et al. Fludarabine increases oxaliplatin cytotoxicity in normal and chronic lymphocytic leukemia lymphocytes by suppressing interstrand DNA crosslink removal. Blood, 2006,108:4187-4193. 被引量：1
  • 9Burnett A, Russell N, Kell J, et al. A phase 2 evaluation of single agent elofarabine as firsl line treatment fur older patients with AML who are not considered fit for intensive chemotherapy. Blood, 2004,104 : abstract 869. 被引量：1
  • 10Burmett A, Baccarani M, Johnson P, et al. Effectiveness of clofarabine in elderl) AML patients with adverse cytogenetics unfit tor intensive chemotherapy. Blood, 2006,108 : abstract 1985. 被引量：1

共引文献1

同被引文献8

引证文献1

儿科药学杂志
2011年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部